STRS Ohio’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$27M Sell
69,859
-4,610
-6% -$1.71M 0.1% 185
2026
Q1
$21.8M Sell
74,469
-2,938
-4% -$966K 0.09% 229
2025
Q4
$27.1M Sell
77,407
-2,902
-4% -$981K 0.1% 193
2025
Q3
$25.9M Buy
80,309
+1,123
+1% +$349K 0.1% 213
2025
Q2
$30.8M Sell
79,186
-64,338
-45% -$25.9M 0.12% 193
2025
Q1
$62.4M Sell
143,524
-612
-0.4% -$246K 0.26% 81
2024
Q4
$53.2M Sell
144,136
-83,621
-37% -$35M 0.21% 90
2024
Q3
$118M Sell
227,757
-2,268
-1% -$1.21M 0.46% 30
2024
Q2
$125M Buy
230,025
+26,016
+13% +$13.8M 0.49% 25
2024
Q1
$106M Sell
204,009
-51,678
-20% -$25.7M 0.42% 38
2023
Q4
$121M Buy
255,687
+58,985
+30% +$27.3M 0.5% 30
2023
Q3
$85.6M Sell
196,702
-8,650
-4% -$3.92M 0.38% 47
2023
Q2
$91.2M Sell
205,352
-5,039
-2% -$2.32M 0.39% 50
2023
Q1
$96.7M Buy
210,391
+2,129
+1% +$1.01M 0.42% 44
2022
Q4
$107M Sell
208,262
-40,984
-16% -$20.8M 0.48% 34
2022
Q3
$113M Buy
249,246
+43,404
+21% +$20.8M 0.54% 30
2022
Q2
$99.3M Sell
205,842
-4,991
-2% -$2.47M 0.45% 43
2022
Q1
$104M Buy
210,833
+41,045
+24% +$18.8M 0.38% 55
2021
Q4
$78.7M Buy
169,788
+3,604
+2% +$1.52M 0.27% 84
2021
Q3
$62M Sell
166,184
-37,073
-18% -$14.1M 0.23% 98
2021
Q2
$77.6M Sell
203,257
-5,204
-2% -$1.99M 0.28% 81
2021
Q1
$74.8M Sell
208,461
-20,103
-9% -$6.46M 0.28% 79
2020
Q4
$73.4M Sell
228,564
-13,267
-5% -$4.07M 0.28% 84
2020
Q3
$65M Sell
241,831
-39,211
-14% -$10.6M 0.27% 83
2020
Q2
$73.9M Buy
281,042
+55,641
+25% +$14.8M 0.32% 63
2020
Q1
$51.2M Sell
225,401
-118,278
-34% -$32.2M 0.27% 85
2019
Q4
$104M Sell
343,679
-3,755
-1% -$1.03M 0.43% 49
2019
Q3
$83.4M Sell
347,434
-27,145
-7% -$7.44M 0.37% 67
2019
Q2
$106M Buy
374,579
+6,747
+2% +$1.84M 0.47% 45
2019
Q1
$106M Buy
367,832
+6,754
+2% +$1.95M 0.48% 43
2018
Q4
$94.8M Buy
361,078
+320
+0.1% +$88K 0.48% 42
2018
Q3
$98.9M Sell
360,758
-24,515
-6% -$6.36M 0.43% 45
2018
Q2
$91.7M Buy
385,273
+2,029
+0.5% +$470K 0.39% 47
2018
Q1
$84.2M Buy
383,244
+229,937
+150% +$54M 0.37% 63
2017
Q4
$34.5M Sell
153,307
-7,491
-5% -$1.6M 0.15% 185
2017
Q3
$30.5M Buy
160,798
+30
+0% +$5.71K 0.13% 208
2017
Q2
$30.2M Sell
160,768
-338
-0.2% -$60.7K 0.13% 207
2017
Q1
$26.6M Sell
161,106
-2,994
-2% -$476K 0.12% 232
2016
Q4
$23.6M Sell
164,100
-2,063
-1% -$276K 0.1% 247
2016
Q3
$20.8M Sell
166,163
-3,621
-2% -$468K 0.09% 274
2016
Q2
$22.3M Sell
169,784
-1,705
-1% -$233K 0.1% 259
2016
Q1
$23.8M Sell
171,489
-134
-0.1% -$17.9K 0.11% 241
2015
Q4
$23.9M Buy
171,623
+5,448
+3% +$750K 0.11% 235
2015
Q3
$23.3M Sell
166,175
-3,831
-2% -$576K 0.11% 244
2015
Q2
$27.9M Sell
170,006
-2,284
-1% -$365K 0.12% 230
2015
Q1
$26.6M Sell
172,290
-7,140
-4% -$1.02M 0.12% 240
2014
Q4
$22.5M Sell
179,430
-3,961
-2% -$489K 0.1% 268
2014
Q3
$21.9M Hold
183,391
0.1% 266
2014
Q2
$19.7M Sell
183,391
-11,345
-6% -$1.17M 0.09% 289
2014
Q1
$19.4M Sell
194,736
-16,000
-8% -$1.45M 0.09% 287
2013
Q4
$19.5M Sell
210,736
-177,300
-46% -$15.8M 0.09% 282
2013
Q3
$32.4M Sell
388,036
-177,488
-31% -$15.2M 0.14% 201
2013
Q2
$46.3M Buy
+565,524
New +$42.3M 0.2% 146

Other funds holding ELV

STRS Ohio's ELV Position: Q2 2026 in Review

STRS Ohio reduced its Elevance Health (ELV) stake by 6.2% in Q2 2026, selling an estimated $1.71M and leaving 69,859 shares worth $27M. The position accounts for 0.1% of the portfolio, ranked #185.

STRS Ohio first reported a position in ELV in Q2 2013 and has held it in 53 quarters since. The position peaked at $125M in Q2 2024. 1,602 funds tracked by Wall St. Rank hold ELV as of Q2 2026.

  • STRS Ohio held 69,859 shares of Elevance Health worth $27M as of Q2 2026.
  • STRS Ohio sold 4,610 Elevance Health shares in Q2 2026, an estimated $1.71M.
  • Elevance Health made up 0.1% of STRS Ohio's portfolio in Q2 2026, its #185 holding.
  • STRS Ohio first reported a position in Elevance Health in Q2 2013 and has held it in 53 quarters since.
  • STRS Ohio's Elevance Health position peaked at $125M in Q2 2024.
  • 1,602 funds tracked by Wall St. Rank held Elevance Health as of Q2 2026.

Based on STRS Ohio's 13F filing for Q2 2026, filed 30 Jul 2026.